SIGN UP
LOG IN
K
09997
Kangji Medical Holdings
7.29
0.03+0.41%Opening11:48 05/12 HKT
OPEN/PREV CLOSE7.220/7.260
TODAY RANGE7.220-7.430
VOL1.20M
MARKET CAP8.81B
52 WEEK RANGE4.910-8.820
AVG VOL (3M)4.73M
% TURNOVER0.10%
TURNOVER8.79M
P/E (TTM)14.026
% RANGE2.89%
EPS(TTM)0.520
P/E(FORWARD)13.384
P/B3.102
BVPS2.350
DIVIDEND0.257
P/S8.919
BETA--
DIV YIELD3.53%
FREE FLOAT MKT CAP8.81B
SHARES OUTSTANDING1.21B
NEXT EARNINGS08/17-08/21
FREE FLOAT1.21B
LOT SIZE500
EX-DIV DATE05/27/2025
News
Press Releases
Financial Reports
Profile
Simply Wall St·04/30 01:47
Kangji Medical Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St·04/22 22:16
The recent 7.9% gain must have brightened CEO Ming Zhong's week, Kangji Medical Holdings Limited's (HKG:9997) most bullish insider
Simply Wall St·03/26 00:10
Kangji Medical Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Reuters·03/24 14:59
KANGJI MEDICAL HOLDINGS FY GROSS MARGIN 79.1%
Simply Wall St·03/16 00:37
Kangji Medical Holdings Limited (HKG:9997) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected
Simply Wall St·02/20 22:12
Kangji Medical Holdings (HKG:9997) Might Be Having Difficulty Using Its Capital Effectively
Simply Wall St·01/23 23:03
Kangji Medical Holdings And 2 Other Undiscovered Gems With Solid Metrics
Simply Wall St·01/02 22:05
Following recent decline, Kangji Medical Holdings Limited's (HKG:9997) top shareholder CEO Ming Zhong sees holdings value drop by 5.7%
Simply Wall St·11/22/2024 23:22
Are Investors Undervaluing Kangji Medical Holdings Limited (HKG:9997) By 47%?
Simply Wall St·08/26/2024 07:14
Kangji Medical Holdings First Half 2024 Earnings: EPS Misses Expectations
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.